Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 1Prostatic Neoplasms 1Cytopenia 1Anemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 2siltuximab 1fludarabine phosphate 1ferric gluconate 1Transplantation 1Tacrolimus 1Pluvicto 1Methotrexate 1Iron-Dextran Complex 1Iron 1Holistic Health 1Filgrastim 1Erythrocyte Transfusion 1Epoetin Alfa 1Busulfan 1Blood Transfusion 1Blood Component Transfusion 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Anemia × Pluvicto × Clear all
NCT07025512 2026-05-08

177Lu-PSMA-617 in Metastatic Castration Resistant Prostate Cancer (mCRPC) With Bone Marrow Involvement and Cytopenia

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Classical hematology

Cytopenia, Anemia, Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡